STOCK TITAN

Health In Tech, Inc. SEC Filings

HIT Nasdaq

Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Trying to follow Health In Tech, Inc.’s rapid insurtech growth? Investors usually begin with the numbers: recurring SaaS fees, broker commission margins and capitalised software costs. Our SEC dashboard surfaces those details instantly, whether you are scanning a Health In Tech quarterly earnings report 10-Q filing for segment revenue or digging into an 8-K material events explained note on a new carrier partnership. No more endless scrolling through EDGAR—just ask and the answers appear.

Powered by Stock Titan’s AI, the platform delivers plain-English explanations of every form. Need Health In Tech insider trading Form 4 transactions before market open? You’ll receive real-time alerts, plus an at-a-glance chart of executive stock transactions Form 4. Wondering how proxy statement executive compensation ties to underwriting profitability? Our AI links the numbers, highlights key clauses and tags peer comparisons. Each filing—10-K, 10-Q, 8-K or S-1—is summarised so you can understand Health In Tech SEC documents with AI instead of poring over accounting jargon.

Because HIT operates at the junction of insurance and healthcare tech, disclosures often address data-privacy liabilities, HIPAA compliance spending and vertical-integration risks. Our earnings report filing analysis identifies those red flags, while the Health In Tech annual report 10-K simplified module breaks down revenue recognition and long-term contract assumptions. Use the timeline view to track Health In Tech Form 4 insider transactions real-time, compare quarter-over-quarter trends, or export tables for valuation models. Comprehensive coverage, live updates and expert context—everything you need to understand this insurtech’s story without the paperwork burden.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Health In Tech, Inc. (HIT) reported an insider grant to Tim Johnson, who is the company's Chief Executive Officer, a director and a >10% owner. On 09/24/2025 Mr. Johnson was granted 80,000 restricted shares of Class A Common Stock under the Health in Tech Equity Incentive Plan at no cash price. The restricted shares vest in three equal tranches, each vesting monthly over a 12-month period tied to milestones: signing a letter of intent or MOU for an initiative, proof-of-concept or beta launch, and full commercial launch. After the grant Mr. Johnson beneficially owns 22,549,741 shares (which the form notes includes 137,495 restricted shares and 22,412,246 Class A shares); the filing excludes 9,000,000 Class B shares and 734,707 options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

LinLin Qian, who serves as Chief Financial Officer, a director and a >10% owner of Health In Tech, Inc. (HIT), received a grant of 80,000 restricted shares of Class A Common Stock on 09/24/2025 at a reported price of $0. Following the grant, the reporting person beneficially owns 8,128,555 shares, which the filing states includes 130,495 restricted shares and 7,998,060 Class A shares (the filing separately excludes 2,700,000 Class B shares and 711,510 options). The restricted shares vest in three equal tranches tied to an initiative: monthly over 12 months after a letter of intent, monthly over 12 months after proof-of-concept or beta launch, and monthly over 12 months after full commercial launch.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Health In Tech, Inc. is soliciting votes for its annual meeting and has mailed a Proxy Statement and Annual Report to holders of record as of August 6, 2025. The filing outlines meeting logistics, voting procedures (including a telephonic proxy deadline of 11:59 p.m. ET on October 2, 2025), broker voting treatment for "routine" items, and deadlines for stockholder proposals and director nomination notices for the 2026 meeting (May 13, 2026 for proposals; August 4, 2026 for contested-nomination notices under Rule 14a-19).

The statement identifies the company's executive officers and board members, describes committee charters and responsibilities (audit, compensation, nominating/governance), discloses a related-party services amounting to $940,915 through May 31, 2023, and notes corporate actions including a retroactive stock split effected June 4, 2024. Director compensation includes an $80,000 restricted stock award for non-employee directors vesting after one year. The Audit Committee reports pre-approval of Malone Bailey's 2024 services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Health In Tech, Inc. (HIT) reporting person LinLin Qian, who serves as Chief Financial Officer, Director and a reported 10% owner, received a grant of 27,000 restricted shares of Class A Common Stock on 08/15/2025. The restricted shares were issued under the Health in Tech Equity Incentive Plan and vest based on operational milestones: 50% vest monthly over 12 months after the first specified program is launched and operational, and the remaining 50% vest monthly over 12 months after the second specified program is launched and operational. Following the transaction the reporting person beneficially owns 8,048,555 shares (which the filing states include 55,193 restricted shares and 7,993,362 Class A shares), while the filing excludes certain Class B shares and options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tim Johnson, the Chief Executive Officer, Director and 10% owner of Health In Tech, Inc. (HIT), was granted 34,000 restricted shares of Class A Common Stock on 08/15/2025. The shares were granted at $0 and are subject to performance-based vesting tied to the successful launch and full operation of two specified company programs: 50% vest monthly over 12 months after the first program is launched and operational, and the remaining 50% vest monthly over 12 months after the second program is launched and operational. After this grant the reporting person beneficially owns 22,469,741 shares, which the filing clarifies includes 62,193 restricted shares and 22,407,548 Class A shares and expressly excludes 9,000,000 Class B shares and 734,707 options to purchase Class A shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Health In Tech, Inc. (HIT) reporting person Imran Yousuf, Chief Technology Officer and Director, received a grant of 7,000 restricted Class A common shares on 08/15/2025. The restricted shares are subject to vesting tied to two separate product launches: 50% vests monthly over 12 months after the first specified program is successfully launched and operational, and the remaining 50% vests monthly over 12 months after the second specified program is successfully launched and operational. Following the grant the reporting person beneficially owns 107,000 shares (comprised of 100,000 shares and 7,000 restricted shares). The filing excludes 100,000 options to purchase Class A common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Health In Tech insider Jonathan Del Lockett reported a grant of 7,000 restricted shares of Class A common stock on 08/15/2025. The restricted shares were granted under the Health in Tech Equity Incentive Plan and carry vesting conditions tied to the successful launch and full operation of two specified company programs: 50% of the restricted shares vest monthly over 12 months after the first program is launched, and the remaining 50% vest monthly over 12 months after the second program is launched. Following the reported transaction, Mr. Lockett beneficially owns 93,539 shares (including 22,105 restricted shares and 71,434 unrestricted Class A shares); the filing notes he also holds 165,085 options to purchase Class A common stock that are excluded from the ownership total.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Health In Tech (HIT)?

The current stock price of Health In Tech (HIT) is $3.49 as of October 8, 2025.

What is the market cap of Health In Tech (HIT)?

The market cap of Health In Tech (HIT) is approximately 200.4M.
Health In Tech, Inc.

Nasdaq:HIT

HIT Rankings

HIT Stock Data

200.43M
13.10M
70.3%
0.82%
0.37%
Software - Application
Insurance Agents, Brokers & Service
Link
United States
STUART